Upgrade to SI Premium - Free Trial

Xylem Reports Fourth Quarter and Full-Year 2021 Earnings

February 3, 2022 6:55 AM

RYE BROOK, N.Y.--(BUSINESS WIRE)-- Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today reported fourth quarter revenue of $1.32 billion, and full-year 2021 revenue of $5.20 billion, in line with previous guidance.

Fourth quarter adjusted earnings before interest, tax, depreciation and amortization (EBITDA) margin decreased 260 basis points to 16.2 percent. Inflation and strategic investments drove the margin decline, exceeding the benefits of price realization and productivity savings. Xylem generated net income of $113 million, or $0.62 per share, and adjusted net income of $115 million, or $0.63 per share, which excludes the impact of restructuring, realignment and special charges.

For the full year, Xylem delivered adjusted EBITDA margin of 17.1 percent, up 80 basis points year-over-year. Productivity and volume drove the increase, exceeding inflation impacts. Full-year reported net income was $427 million, or $2.35 per share, and adjusted net income, which excludes the impact of restructuring, realignment and special charges, was $452 million, or $2.49 per share. The Company generated $538 million of operating cash flow, representing a 126 percent conversion, and $330 million of free cash flow, representing a 77 percent conversion.

“The team closed out 2021 with a strong performance, delivering full-year margin expansion alongside solid growth in revenue and earnings in the face of accelerating supply chain headwinds through the quarter,” said Patrick Decker, president and CEO of Xylem. “To mitigate the effects of inflation, the team also drove solid productivity improvements and price realization above our expectations. Market demand was clearly robust, as evidenced by continued strong orders and backlog growth in both the quarter and the year.”

“We expect the first half of 2022 to continue to be supply constrained due to ongoing chip shortages,” Decker continued. “Order-to-revenue conversion is set to pick up pace progressively, as we expect those constraints to begin easing in the latter part of the year. Overall, we expect full-year growth in the mid-single digits, with significant margin expansion in the second half, keeping us on track to achieve our 2025 growth and strategic milestones.”

Xylem announced that its Board of Directors declared a dividend in the amount of $0.30 per share, an increase of 7 percent. The dividend is payable on March 17, 2022, to shareholders of record as of February 17, 2022.

Full-year 2022 Outlook

Xylem forecasts full-year 2022 revenue in the range of $5.25 to $5.35 billion, up 1 to 3 percent on a reported basis and up 3 to 5 percent on an organic basis.

Full-year 2022 adjusted EBITDA margin is expected to be in the range of 16 to 17 percent. This results in adjusted earnings per share of $2.35 to $2.70, which represents a decline of 6 percent to an increase of 8 percent from Xylem’s 2021 adjusted results. Further 2022 planning assumptions are included in Xylem’s fourth quarter 2021 earnings materials posted at www.xylem.com/investors. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.

Fourth Quarter Segment Results

Water Infrastructure

Xylem’s Water Infrastructure segment consists of its portfolio of businesses serving clean water delivery, wastewater transport and treatment, and dewatering.

Applied Water

Xylem’s Applied Water segment consists of its portfolio of businesses in residential and commercial building services, and industrial applications.

Measurement & Control Solutions

Xylem’s Measurement & Control Solutions segment consists of its portfolio of businesses in smart metering, network technologies, advanced infrastructure analytics and analytic instrumentation.

Supplemental information on Xylem’s fourth quarter 2021 earnings and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.

About Xylem

Xylem (XYL) is a leading global water technology company committed to solving critical water and infrastructure challenges with innovation. Our 17,000 diverse employees delivered revenue of $5.2 billion in 2021. We are creating a more sustainable world by enabling our customers to optimize water and resource management, and helping communities in more than 150 countries become water-secure. Join us at www.xylem.com.

Forward-Looking Statements

This press release contains “forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” "contemplate," "predict," “forecast,” “likely,” “believe,” “target,” “will,” “could,” “would,” “should,” "potential," "may" and similar expressions or their negative, may, but are not necessary to, identify forward-looking statements. By their nature, forward-looking statements address uncertain matters and include any statements that: are not historical, such as statements about our strategy, financial plans, outlook, objectives, plans, intentions or goals (including those related to our social, environmental and other sustainability goals); or address possible or future results of operations or financial performance, including statements relating to orders, revenues, operating margins and earnings per share growth.

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Additionally, many of these risks and uncertainties are, and may continue to be, amplified by the ongoing coronavirus (“COVID-19”) pandemic. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include, among others, the following: overall industry and economic conditions, including industrial, governmental and private sector spending and the strength of the residential and commercial real estate markets; geopolitical, regulatory, economic and other risks associated with international operations; continued uncertainty around the ongoing COVID-19 pandemic’s magnitude, duration and impacts on our business, operations, growth, and financial condition; actual or potential other epidemics, pandemics or global health crises; availability, shortage or delays in receiving products, parts, electronic components and raw materials from our supply chain; manufacturing and operating cost increases due to inflation, prevailing price changes, tariffs and other factors; demand for our products, disruption, competition, pricing pressures in the markets we serve; cybersecurity incidents or other disruptions of information technology systems on which we rely, or involving our products; disruptions in operations at our facilities or that of third parties upon which we rely; ability to retain and attract senior management and other diverse and key talent, as well as increasing competition for overall talent and labor; difficulty predicting our financial results; defects, security, warranty and liability claims, and recalls with respect to products; availability, regulation or interference with radio spectrum used by certain of our products; uncertainty related to restructuring and realignment actions and related charges and savings; our ability to continue strategic investments for growth; our ability to successfully identify, execute and integrate acquisitions; volatility in served markets or impacts on business and operations due to weather conditions, including the effects of climate change; fluctuations in foreign currency exchange rates; our ability to borrow or refinance our existing indebtedness and the availability of liquidity sufficient to meet our needs; risk of future impairments to goodwill and other intangible assets; failure to comply with, or changes in, laws or regulations, including those pertaining to anti-corruption, data privacy and security, export and import, competition, domestic content requirements, and the environment and climate change; changes in our effective tax rates or tax expenses; legal, governmental or regulatory claims, investigations or proceedings and associated contingent liabilities; and other factors set forth under "Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020 and in subsequent filings we have made or may make with the Securities and Exchange Commission (“SEC”).

Forward-looking and other statements in this press release regarding our environmental and other sustainability plans and goals are not an indication that these statements are necessarily material to investors or required to be disclosed in our filings with the SEC. In addition, historical, current, and forward-looking social, environmental and sustainability-related statements may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future.

All forward-looking statements made herein are based on information currently available to us as of the date of this press release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

XYLEM INC. AND SUBSIDIARIES

CONSOLIDATED INCOME STATEMENTS (Unaudited)

(In Millions, except per share data)

Year Ended December 31,

2021

2020

2019

Revenue

$

5,195

$

4,876

$

5,249

Cost of revenue

3,220

3,046

3,203

Gross profit

1,975

1,830

2,046

Selling, general and administrative expenses

1,179

1,143

1,158

Research and development expenses

204

187

191

Restructuring and asset impairment charges

7

75

63

Goodwill impairment charge

58

148

Operating income

585

367

486

Interest expense

76

77

67

Other non-operating (expense) income, net

(5

)

(4

)

Gain on sale of businesses

2

1

Income before taxes

511

285

416

Income tax expense

84

31

15

Net income

427

254

401

Earnings per share:

Basic

$

2.37

$

1.41

$

2.23

Diluted

$

2.35

$

1.40

$

2.21

Weighted average number of shares:

Basic

180.2

180.1

180.0

Diluted

181.5

181.1

181.2

XYLEM INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS (Unaudited)

(In Millions, except per share amounts)

December 31,

2021

2020

ASSETS

Current assets:

Cash and cash equivalents

$

1,349

$

1,875

Receivables, less allowances for discounts, returns and credit losses of $44 and $46 in 2021 and 2020, respectively

953

923

Inventories

700

558

Prepaid and other current assets

158

167

Total current assets

3,160

3,523

Property, plant and equipment, net

644

657

Goodwill

2,792

2,854

Other intangible assets, net

1,016

1,093

Other non-current assets

664

623

Total assets

$

8,276

$

8,750

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Accounts payable

$

639

$

569

Accrued and other current liabilities

752

787

Short-term borrowings and current maturities of long-term debt

600

Total current liabilities

1,391

1,956

Long-term debt, net

2,440

2,484

Accrued post-retirement benefits

438

519

Deferred income tax liabilities

287

242

Other non-current accrued liabilities

494

573

Total liabilities

5,050

5,774

Stockholders’ equity:

Common stock — par value $0.01 per share:

Authorized 750.0 shares, issued 195.6 and 194.9 shares in 2021 and 2020, respectively

2

2

Capital in excess of par value

2,089

2,037

Retained earnings

2,154

1,930

Treasury stock – at cost 15.2 shares and 14.5 shares in 2021 and 2020, respectively

(656

)

(588

)

Accumulated other comprehensive loss

(371

)

(413

)

Total stockholders’ equity

3,218

2,968

Non-controlling interest

8

8

Total equity

3,226

2,976

Total liabilities and stockholders’ equity

$

8,276

$

8,750

XYLEM INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (In Millions) (Unaudited)

Year Ended December 31,

2021

2020

2019

Operating Activities

Net income

$

427

$

254

$

401

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation

118

117

117

Amortization

127

134

140

Deferred income taxes

10

(31

)

(77

)

Share-based compensation

33

26

29

Restructuring and asset impairment charges

7

75

63

Goodwill impairment charge

58

148

Gain from sale of businesses

(2

)

(1

)

Other, net

8

46

9

Payments for restructuring

(25

)

(36

)

(30

)

Contributions to post-retirement benefit plans

(29

)

(27

)

(19

)

Changes in assets and liabilities (net of acquisitions):

Changes in receivables

(70

)

109

(23

)

Changes in inventories

(167

)

(5

)

47

Changes in accounts payable

81

(39

)

29

Changes in accrued liabilities

7

101

15

Changes in accrued taxes

(9

)

20

(13

)

Net changes in other assets and liabilities

22

22

4

Net Cash — Operating activities

538

824

839

Investing Activities

Capital expenditures

(208

)

(183

)

(226

)

Acquisitions of businesses and assets, net of cash acquired

(18

)

Proceeds from sale of businesses

10

Cash received from investments

3

200

11

Cash paid for investments

(200

)

(7

)

Cash received from cross-currency swaps

14

12

9

Other, net

(2

)

2

Net Cash — Investing activities

(183

)

(169

)

(231

)

Financing Activities

Short-term debt issued, net

359

281

Short-term debt repaid, net

(640

)

(254

)

Long-term debt issued, net

985

Long-term debt repaid, net

(600

)

Repurchase of common stock

(68

)

(61

)

(40

)

Proceeds from exercise of employee stock options

19

20

13

Dividends paid

(203

)

(188

)

(174

)

Other, net

(3

)

(2

)

(3

)

Net Cash — Financing activities

(855

)

473

(177

)

Effect of exchange rate changes on cash

(26

)

23

(3

)

Net change in cash and cash equivalents

(526

)

1,151

428

Cash and cash equivalents at beginning of year

1,875

724

296

Cash and cash equivalents at end of year

$

1,349

$

1,875

$

724

Supplemental disclosure of cash flow information:

Cash paid during the year for:

Interest

$

99

$

77

$

77

Income taxes (net of refunds received)

$

83

$

41

$

107

Xylem Inc. Non-GAAP Measures
Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following items to represent the non-GAAP measures we consider to be key performance indicators, as well as the related reconciling items to the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP measures may not be comparable to similarly titled measures reported by other companies.
“Organic revenue" and "Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales or discontinuance of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.
“Constant currency” defined as financial results adjusted for foreign currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar.
“EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense. “Adjusted EBITDA” and "Adjusted Segment EBITDA" reflects the adjustments to EBITDA and segment EBITDA, respectively, to exclude share-based compensation charges, restructuring and realignment costs, gain or loss from sale of businesses and special charges.
"Adjusted EBITDA Margin" and "Adjusted Segment EBITDA margin" defined as adjusted EBITDA and adjusted segment EBITDA divided by total revenue and segment revenue, respectively.
"Adjusted Operating Income", "Adjusted Segment Operating Income", "Adjusted Net Income" and “Adjusted EPS” defined as operating income, segment operating income, net income and earnings per share, adjusted to exclude restructuring and realignment costs, gain or loss from sale of businesses, special charges and tax-related special items, as applicable.
"Adjusted Operating Margin" and "Adjusted Segment Operating Margin" defined as adjusted operating income and adjusted segment operating income divided by total revenue and segment revenue, respectively.
“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flows, less capital expenditures, and "Free Cash Flow Conversion" defined as Free Cash Flows divided by net income, excluding the gain on sale of businesses, non-cash impairment charges and significant deferred tax items. Our definitions of "free cash flow" and "free cash flow conversion" do not consider certain non-discretionary cash payments, such as debt.
“Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.
“Special charges" defined as costs incurred by the Company, such as acquisition and integration related costs, non-cash impairment charges and both operating and non-operating adjustments for costs related to the UK pension plan buyout.
“Tax-related special items" defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, excess tax benefits/losses and other discrete tax adjustments.
Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Orders ($ Millions)
(As Reported - GAAP) (As Adjusted - Organic) Constant Currency
(A) (B) (C) (D) (E) = B+C+D (F) = E/A (G) = (E - C) / A
Change % Change Acquisitions /
Divestitures
Change % Change
Orders Orders 2021 v. 2020 2021 v. 2020 FX Impact Adj. 2021 v. 2020 Adj. 2021 v. 2020

2021

2020

Year Ended December 31
Xylem Inc.

6,300

5,033

1,267

25

%

12

(140

)

1,139

23

%

22

%

Water Infrastructure

2,471

2,134

337

16

%

-

(76

)

261

12

%

12

%

Applied Water

1,860

1,483

377

25

%

-

(39

)

338

23

%

23

%

Measurement & Control Solutions

1,969

1,416

553

39

%

12

(25

)

540

38

%

37

%

Quarter Ended December 31
Xylem Inc.

1,584

1,294

290

22

%

2

7

299

23

%

23

%

Water Infrastructure

598

464

134

29

%

-

4

138

30

%

30

%

Applied Water

451

410

41

10

%

-

1

42

10

%

10

%

Measurement & Control Solutions

535

420

115

27

%

2

2

119

28

%

28

%

Quarter Ended September 30
Xylem Inc.

1,518

1,246

272

22

%

2

(24

)

250

20

%

20

%

Water Infrastructure

623

558

65

12

%

-

(12

)

53

9

%

9

%

Applied Water

446

375

71

19

%

-

(7

)

64

17

%

17

%

Measurement & Control Solutions

449

313

136

43

%

2

(5

)

133

42

%

42

%

Quarter Ended June 30
Xylem Inc.

1,660

1,232

428

35

%

1

(74

)

355

29

%

29

%

Water Infrastructure

639

598

41

7

%

-

(41

)

-

0

%

0

%

Applied Water

486

326

160

49

%

-

(20

)

140

43

%

43

%

Measurement & Control Solutions

535

308

227

74

%

1

(13

)

215

70

%

69

%

Quarter Ended March 31
Xylem Inc.

1,538

1,261

277

22

%

7

(49

)

235

19

%

18

%

Water Infrastructure

611

514

97

19

%

-

(27

)

70

14

%

14

%

Applied Water

477

372

105

28

%

-

(13

)

92

25

%

25

%

Measurement & Control Solutions

450

375

75

20

%

7

(9

)

73

19

%

18

%

Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Revenue ($ Millions)
(As Reported - GAAP) (As Adjusted - Organic) Constant Currency
(A) (B) (C) (D) (E) = B+C+D (F) = E/A (G) = (E - C) / A
Change % Change Acquisitions /
Divestitures
Change % Change
Revenue Revenue 2021 v. 2020 2021 v. 2020 FX Impact Adj. 2021 v. 2020 Adj. 2021 v. 2020

2021

2020

Year Ended December 31
Xylem Inc.

5,195

4,876

319

7

%

13

(122

)

210

4

%

4

%

Water Infrastructure

2,247

2,079

168

8

%

-

(65

)

103

5

%

5

%

Applied Water

1,613

1,434

179

12

%

-

(34

)

145

10

%

10

%

Measurement & Control Solutions

1,335

1,363

(28

)

(2

%)

13

(23

)

(38

)

(3

%)

(4

%)

Quarter Ended December 31
Xylem Inc.

1,323

1,373

(50

)

(4

%)

6

8

(36

)

(3

%)

(3

%)

Water Infrastructure

622

616

6

1

%

-

5

11

2

%

2

%

Applied Water

406

395

11

3

%

-

2

13

3

%

3

%

Measurement & Control Solutions

295

362

(67

)

(19

%)

6

1

(60

)

(17

%)

(18

%)

Quarter Ended September 30
Xylem Inc.

1,265

1,220

45

4

%

2

(20

)

27

2

%

2

%

Water Infrastructure

547

524

23

4

%

-

(10

)

13

2

%

2

%

Applied Water

400

364

36

10

%

-

(7

)

29

8

%

8

%

Measurement & Control Solutions

318

332

(14

)

(4

%)

2

(3

)

(15

)

(5

%)

(5

%)

Quarter Ended June 30
Xylem Inc.

1,351

1,160

191

16

%

3

(66

)

128

11

%

11

%

Water Infrastructure

569

501

68

14

%

-

(36

)

32

6

%

6

%

Applied Water

414

337

77

23

%

-

(18

)

59

18

%

18

%

Measurement & Control Solutions

368

322

46

14

%

3

(12

)

37

11

%

11

%

Quarter Ended March 31
Xylem Inc.

1,256

1,123

133

12

%

2

(44

)

91

8

%

8

%

Water Infrastructure

509

438

71

16

%

-

(24

)

47

11

%

11

%

Applied Water

393

338

55

16

%

-

(11

)

44

13

%

13

%

Measurement & Control Solutions

354

347

7

2

%

2

(9

)

-

0

%

(1

%)

Xylem Inc. Non-GAAP Reconciliation
Adjusted Operating Income ($ Millions)
Q1 Q2 Q3 Q4 YTD

2021

2020

2021

2020

2021

2020

2021

2020

2021

2020

Total Revenue
• Total Xylem

1,256

1,123

1,351

1,160

1,265

1,220

1,323

1,373

5,195

4,876

• Water Infrastructure

509

438

569

501

547

524

622

616

2,247

2,079

• Applied Water

393

338

414

337

400

364

406

395

1,613

1,434

• Measurement & Control Solutions

354

347

368

322

318

332

295

362

1,335

1,363

Operating Income (Loss)
• Total Xylem

133

61

160

54

152

73

140

179

585

367

• Water Infrastructure

71

39

93

73

101

89

122

117

387

318

• Applied Water

66

47

64

41

60

56

50

61

240

205

• Measurement & Control Solutions

9

(12

)

13

(46

)

7

(62

)

(17

)

14

12

(106

)

• Total Segments

146

74

170

68

168

83

155

192

639

417

Operating Margin
• Total Xylem

10.6

%

5.4

%

11.8

%

4.7

%

12.0

%

6.0

%

10.6

%

13.0

%

11.3

%

7.5

%

• Water Infrastructure

13.9

%

8.9

%

16.3

%

14.6

%

18.5

%

17.0

%

19.6

%

19.0

%

17.2

%

15.3

%

• Applied Water

16.8

%

13.9

%

15.5

%

12.2

%

15.0

%

15.4

%

12.3

%

15.4

%

14.9

%

14.3

%

• Measurement & Control Solutions

2.5

%

(3.5

%)

3.5

%

(14.3

%)

2.2

%

(18.7

%)

(5.8

%)

3.9

%

0.9

%

(7.8

%)

• Total Segments

11.6

%

6.6

%

12.6

%

5.9

%

13.3

%

6.8

%

11.7

%

14.0

%

12.3

%

8.6

%

Special Charges
• Total Xylem

2

-

-

11

1

70

1

-

4

81

• Water Infrastructure

-

-

-

-

-

-

-

-

-

-

• Applied Water

1

-

-

-

-

-

-

-

1

-

• Measurement & Control Solutions

-

-

-

10

-

69

-

-

-

79

• Total Segments

1

-

-

10

-

69

-

-

1

79

Restructuring & Realignment Costs
• Total Xylem

8

9

6

43

2

15

6

10

22

77

• Water Infrastructure

5

5

4

8

1

8

2

7

12

28

• Applied Water

1

2

2

4

2

2

2

1

7

9

• Measurement & Control Solutions

2

2

-

31

(1

)

5

2

2

3

40

• Total Segments

8

9

6

43

2

15

6

10

22

77

Adjusted Operating Income (Loss)
• Total Xylem

143

70

166

108

155

158

147

189

611

525

• Water Infrastructure

76

44

97

81

102

97

124

124

399

346

• Applied Water

68

49

66

45

62

58

52

62

248

214

• Measurement & Control Solutions

11

(10

)

13

(5

)

6

12

(15

)

16

15

13

• Total Segments

155

83

176

121

170

167

161

202

662

573

Adjusted Operating Margin
• Total Xylem

11.4

%

6.2

%

12.3

%

9.3

%

12.3

%

13.0

%

11.1

%

13.8

%

11.8

%

10.8

%

• Water Infrastructure

14.9

%

10.0

%

17.0

%

16.2

%

18.6

%

18.5

%

19.9

%

20.1

%

17.8

%

16.6

%

• Applied Water

17.3

%

14.5

%

15.9

%

13.4

%

15.5

%

15.9

%

12.8

%

15.7

%

15.4

%

14.9

%

• Measurement & Control Solutions

3.1

%

(2.9

%)

3.5

%

(1.6

%)

1.9

%

3.6

%

(5.1

%)

4.4

%

1.1

%

1.0

%

• Total Segments

12.3

%

7.4

%

13.0

%

10.4

%

13.4

%

13.7

%

12.2

%

14.7

%

12.7

%

11.8

%

Xylem Inc. Non-GAAP Reconciliation
Adjusted Diluted EPS
($ Millions, except per share amounts)
Q4 2021 Q4 2020
As Reported Adjustments Adjusted As Reported Adjustments Adjusted
Total Revenue

1,323

-

1,323

1,373

-

1,373

Operating Income

140

7

a

147

179

10

a

189

Operating Margin

10.6

%

11.1

%

13.0

%

13.8

%

Interest Expense

(13

)

-

(13

)

(21

)

-

(21

)

Other Non-Operating Income (Expense)

(1

)

3

b

2

-

1

b

1

Gain/(Loss) From Sale of Business

-

-

-

-

-

-

Income before Taxes

126

10

136

158

11

169

Provision for Income Taxes

(13

)

(8

)

c

(21

)

(10

)

(14

)

c

(24

)

Net Income Attributable to Xylem

113

2

115

148

(3

)

145

Diluted Shares

181.6

181.6

181.5

181.5

Diluted EPS

$

0.62

$

0.01

$

0.63

$

0.82

$

(0.01

)

$

0.81

Year-over-year currency translation impact on current year diluted EPS

$

(0.01

)

$

-

$

(0.01

)

Diluted EPS at Constant Currency

$

0.63

$

0.01

$

0.64

Q4 YTD 2021 Q4 YTD 2020
As Reported Adjustments Adjusted As Reported Adjustments Adjusted
Total Revenue

5,195

-

5,195

4,876

-

4,876

Operating Income

585

26

a

611

367

158

a

525

Operating Margin

11.3

%

11.8

%

7.5

%

10.8

%

Interest Expense

(76

)

-

(76

)

(77

)

-

(77

)

Other Non-Operating Income (Expense)

-

8

b

8

(5

)

5

b

-

Gain/(Loss) From Sale of Business

2

(2

)

-

-

-

-

Income before Taxes

511

32

543

285

163

448

Provision for Income Taxes

(84

)

(7

)

c

(91

)

(31

)

(43

)

c

(74

)

Net Income Attributable to Xylem

427

25

452

254

120

374

Diluted Shares

181.5

181.5

181.1

181.0

Diluted EPS

$

2.35

$

0.14

$

2.49

$

1.40

$

0.66

$

2.06

Year-over-year currency translation impact on current year diluted EPS

$

0.08

$

0.01

$

0.09

Diluted EPS at Constant Currency

$

2.27

$

0.13

$

2.40

a Quarter-to-date: Restructuring & realignment costs of $6 million in 2021 and $10 million in 2020, as well as special charges of $1 million in 2021.
Year-to-date: Restructuring & realignment costs of $22 million and $77 million in 2021 and 2020, respectively; special charges of $4 million ($1 million of intangible asset impairment charges and $3 million of other charges) and $81 million of special charges in 2020 ($79 million of intangible asset and goodwill impairment charges and $2 million of other charges).
b Quarter-to-date: Special non-operating charges consist of $3 million in 2021 and $1 million in 2020 for costs related to the UK pension plan that is going to be part of a buyout.
Year-to-date: Special non-operating charges consist of $8 million in 2021 and $5 million in 2020 for costs related to the UK pension plan that is going to be part of a buyout .
c Quarter-to-date: Net tax impact on restructuring & realignment costs of $1 million in 2021 and $2 million in 2020; $1 million net tax impact on special charges in each of 2021 and 2020 and $6 million and $11 million in 2021 and 2020, respectively, of negative impact from tax related special benefits to GAAP tax.
Year-to-date: Net tax impact on restructuring & realignment costs of $5 million and $17 million in 2021 and 2020, respectively; $2 million and $10 million of net tax impact on special charges in 2021 and 2020, respectively; and $16 million in 2020 of negative impact from tax related special benefits to GAAP tax.
Xylem Inc. Non-GAAP Reconciliation
Net Cash - Operating Activities vs. Free Cash Flow ($ Millions)

Q1

Q2

Q3

Q4

Year-to-Date

2021

2020

2021

2020

2021

2020

2021

2020

2021

2020

Net Cash - Operating Activities

$

(26

)

$

(2

)

$

232

$

181

$

112

$

275

$

220

$

370

$

538

$

824

Capital Expenditures - PP&E

(22

)

(32

)

(25

)

(24

)

(33

)

(24

)

(62

)

(29

)

(142

)

(109

)

Capital Expenditures - Software

(17

)

(19

)

(16

)

(20

)

(14

)

(17

)

(19

)

(18

)

(66

)

(74

)

Capital Expenditures

(39

)

(51

)

(41

)

(44

)

(47

)

(41

)

(81

)

(47

)

(208

)

(183

)

Free Cash Flow

$

(65

)

$

(53

)

$

191

$

137

$

65

$

234

$

139

$

323

$

330

$

641

Net Income

87

38

113

31

114

37

113

148

427

254

Gain/(Loss) from sale of business

-

-

2

-

-

-

-

-

2

-

Restructuring & Realignment Charges - non-cash impairment

(1

)

-

-

(17

)

-

(3

)

-

(1

)

(1

)

(21

)

Special Charges - non-cash impairment

(1

)

-

-

(10

)

-

(69

)

-

-

(1

)

(79

)

Net Income, excluding gain on sale of businesses, non-cash impairment charges and significant deferred tax items

$

89

$

38

$

111

$

58

$

114

$

109

$

113

$

149

$

427

$

354

Operating Cash Flow Conversion

(30

%)

(5

%)

205

%

584

%

98

%

743

%

195

%

250

%

126

%

324

%

Free Cash Flow Conversion

(73

%)

(139

%)

172

%

236

%

57

%

215

%

123

%

217

%

77

%

181

%

Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)

2021

Q1 Q2 Q3 Q4 Total
Net Income

87

113

114

113

427

Income Tax Expense

27

25

19

13

84

Interest Expense (Income), net

19

19

20

11

69

Depreciation

30

29

31

28

118

Amortization

32

33

31

31

127

EBITDA

195

219

215

196

825

Share-based Compensation

9

8

8

8

33

Restructuring & Realignment

8

6

2

6

22

Loss/(Gain) from sale of business

-

(2

)

-

-

(2

)

Special Charges

3

3

2

4

12

Adjusted EBITDA

215

234

227

214

890

Revenue

1,256

1,351

1,265

1,323

5,195

Adjusted EBITDA Margin

17.1

%

17.3

%

17.9

%

16.2

%

17.1

%

2020

Q1 Q2 Q3 Q4 Total
Net Income

38

31

37

148

254

Income Tax Expense

4

4

13

10

31

Interest Expense (Income), net

14

16

20

20

70

Depreciation

29

29

30

29

117

Amortization

35

33

33

33

134

EBITDA

120

113

133

240

606

Share-based Compensation

8

8

3

7

26

Restructuring & Realignment

9

43

15

10

77

Special Charges

1

13

71

1

86

Adjusted EBITDA

138

177

222

258

795

Revenue

1,123

1,160

1,220

1,373

4,876

Adjusted EBITDA Margin

12.3

%

15.3

%

18.2

%

18.8

%

16.3

%

Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
Water Infrastructure

2021

Q1 Q2 Q3 Q4 Total
Pre-Tax Income

70

92

102

121

385

Interest Expense (Income), net

(1

)

(1

)

-

(1

)

(3

)

Depreciation

11

11

11

10

43

Amortization

2

2

1

3

8

EBITDA

82

104

114

133

433

Share-based Compensation

1

-

1

-

2

Restructuring & Realignment

5

4

1

2

12

Adjusted EBITDA

88

108

116

135

447

Revenue

509

569

547

622

2,247

Adjusted EBITDA Margin

17.3

%

19.0

%

21.2

%

21.7

%

19.9

%

2020

Q1 Q2 Q3 Q4 Total
Pre-Tax Income

37

71

85

116

309

Interest Expense (Income), net

-

(1

)

-

-

(1

)

Depreciation

11

11

11

11

44

Amortization

4

5

2

2

13

EBITDA

52

86

98

129

365

Share-based Compensation

-

1

-

1

2

Restructuring & Realignment

5

8

8

7

28

Adjusted EBITDA

57

95

106

137

395

Revenue

438

501

524

616

2,079

Adjusted EBITDA Margin

13.0

%

19.0

%

20.2

%

22.2

%

19.0

%

Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
Applied Water

2021

Q1 Q2 Q3 Q4 Total
Pre-Tax Income

66

65

60

48

239

Interest Expense (Income), net

-

-

-

-

-

Depreciation

5

5

5

5

20

Amortization

1

1

-

-

2

EBITDA

72

71

65

53

261

Share-based Compensation

1

1

1

1

4

Restructuring & Realignment

1

2

2

2

7

Loss/(Gain) from sale of business

-

(2

)

-

-

(2

)

Special Charges

1

-

-

-

1

Adjusted EBITDA

75

72

68

56

271

Revenue

393

414

400

406

1,613

Adjusted EBITDA Margin

19.1

%

17.4

%

17.0

%

13.8

%

16.8

%

2020

Q1 Q2 Q3 Q4 Total
Pre-Tax Income

47

42

55

60

204

Interest Expense (Income), net

-

-

-

-

-

Depreciation

5

5

6

5

21

Amortization

1

-

1

1

3

EBITDA

53

47

62

66

228

Share-based Compensation

1

1

-

1

3

Restructuring & Realignment

2

4

2

1

9

Adjusted EBITDA

56

52

64

68

240

Revenue

338

337

364

395

1,434

Adjusted EBITDA Margin

16.6

%

15.4

%

17.6

%

17.2

%

16.7

%

Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
Measurement & Control Solutions

2021

Q1 Q2 Q3 Q4 Total
Pre-Tax Income

*

8

12

7

(17

)

10

Interest Expense (Income), net

-

-

-

-

-

Depreciation

9

10

11

8

38

Amortization

27

27

27

26

107

EBITDA

44

49

45

17

155

Share-based Compensation

1

2

1

2

6

Restructuring & Realignment

2

-

(1

)

2

3

Adjusted EBITDA

47

51

45

21

164

Revenue

354

368

318

295

1,335

Adjusted EBITDA Margin

13.3

%

13.9

%

14.2

%

7.1

%

12.3

%

2020

Q1 Q2 Q3 Q4 Total
Pre-Tax (Loss) Income

(13

)

(46

)

(62

)

14

(107

)

Interest Expense (Income), net

-

-

-

-

-

Depreciation

9

8

9

9

35

Amortization

27

26

27

27

107

EBITDA

23

(12

)

(26

)

50

35

Share-based Compensation

2

1

1

1

5

Restructuring & Realignment

2

31

5

2

40

Special Charges

-

10

69

-

79

Adjusted EBITDA

27

30

49

53

159

Revenue

347

322

332

362

1,363

Adjusted EBITDA Margin

7.8

%

9.3

%

14.8

%

14.6

%

11.7

%

*Revised from previously reported Q1 income to adjust for a one-time income item that offsets with Corporate and Other in consolidation.

Media

Houston Spencer +1 (914) 323-5723

[email protected]



Investors

Matt Latino +1 (914) 323-5821

[email protected]

Source: Xylem Inc.

Categories

Business Wire Press Releases

Next Articles